Supply: vchal/Shutterstock
Bellicum Prescription drugs (NASDAQ:BLCM) inventory is rising greater on Monday morning following information of an funding within the firm.
In line with a submitting with the SEC, Baker Bros. Advisors LP has taken a 19.99% stake in Bellicum Prescription drugs. This comes from its 9,046,298 shares of BLCM inventory, in addition to 1,948,796 shares obtainable by pre-funded inventory warrants which are exercisable inside 60 days.
Information of that funding was reported on Friday, which resulted in BLCM inventory rising in pre-market buying and selling right this moment. That is sensible because the funding from Baker Bros. Advisors LP is main and has probably kicked off curiosity within the inventory.
We’re seeing that right this moment with shares of BLCM inventory seeing heavy buying and selling on Monday. As of this writing, greater than 3.8 million shares of the corporate’s inventory have modified fingers. To place that in perspective, the each day common buying and selling quantity for Bellicum Prescription drugs inventory is nearer to 1.2 million shares.
What To Know About BLCM Inventory
Bellicum Prescription drugs is a mobile immunotherapies firm that operates out of Houston, Texas. The corporate was based in 2004 and went public through a $160 million preliminary public providing (IPO) in 2014. For perspective, that IPO valued BLCM inventory at $16 per share and it closed Friday at 40 cents per share.
BLCM inventory is up 74.5% as of Monday morning.
Traders looking for extra of the latest inventory market information will wish to maintain studying!
InvestorPlace is dwelling to all the newest inventory market information value studying about on Monday! That features the most important pre-market inventory movers this morning, the most recent GameStop (NYSE:GME) worth predictions, and extra. You possibly can make amends for all of this information on the following hyperlinks!
Extra Monday Inventory Market Information
On the date of publication, William White didn’t have (both immediately or not directly) any positions within the securities talked about on this article. The opinions expressed on this article are these of the author, topic to the InvestorPlace.com Publishing Pointers.
With solely the rarest exceptions, InvestorPlace doesn’t publish commentary about corporations which have a market cap of lower than $100 million or commerce lower than 100,000 shares every day. That’s as a result of these “penny shares” are regularly the playground for rip-off artists and market manipulators. If we ever do publish commentary on a low-volume inventory which may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this reality and warn readers of the dangers.
Learn Extra: Penny Shares — How one can Revenue With out Getting Scammed
